Recombinant Human TNFAIP3 Protein is a Human Fragment protein, in the 2 to 439 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
>=95% HPLC
<= 0.005 EU/µg
HEK 293 cells
Tag free
HPLC, MS, SDS-PAGE
No
A E Q V L P Q A L Y L S N M R K A V K I R E R T P E D I F K P T N G I I H H F K T M H R Y T L E M F R T C Q F C P Q F R E I I H K A L I D R N I Q A T L E S Q K K L N W C R E V R K L V A L K T N G D G N C L M H A T S Q Y M W G V Q D T D L V L R K A L F S T L K E T D T R N F K F R W Q L E S L K S Q E F V E T G L C Y D T R N W N D E W D N L I K M A S T D T P M A R S G L Q Y N S L E E I H I F V L C N I L R R P I I V I S D K M L R S L E S G S N F A P L K V G G I Y L P L H W P A Q E C Y R Y P I V L G Y D S H H F V P L V T L K D S G P E I R A V P L V N R D R G R F E D L K V H F L T D P E N E M K E K L L K E Y L M V I E I P V Q G W D H G T T H L I N A A K L D E A N L P K E I N L V D D Y F E L V Q H E Y K K W Q E N S E Q G R R E G H A Q N P M E P S V P Q L S L M D V K C E T P N C P F F M S V N T Q P L C H E C S E R R Q K N Q N K L P K L N S K P G P E G L P G M A L G A S R
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerized macrophages.
OTUD7C, TNFAIP3, OTUD7C, Tumor necrosis factor alpha-induced protein 3, TNF alpha-induced protein 3, OTU domain-containing protein 7C, Putative DNA-binding protein A20, Zinc finger protein A20
Recombinant Human TNFAIP3 Protein is a Human Fragment protein, in the 2 to 439 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for HPLC, MS, SDS-PAGE.
>=95% HPLC
<= 0.005 EU/µg
HEK 293 cells
Tag free
HPLC, MS, SDS-PAGE
No
Yes
Human
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic
A E Q V L P Q A L Y L S N M R K A V K I R E R T P E D I F K P T N G I I H H F K T M H R Y T L E M F R T C Q F C P Q F R E I I H K A L I D R N I Q A T L E S Q K K L N W C R E V R K L V A L K T N G D G N C L M H A T S Q Y M W G V Q D T D L V L R K A L F S T L K E T D T R N F K F R W Q L E S L K S Q E F V E T G L C Y D T R N W N D E W D N L I K M A S T D T P M A R S G L Q Y N S L E E I H I F V L C N I L R R P I I V I S D K M L R S L E S G S N F A P L K V G G I Y L P L H W P A Q E C Y R Y P I V L G Y D S H H F V P L V T L K D S G P E I R A V P L V N R D R G R F E D L K V H F L T D P E N E M K E K L L K E Y L M V I E I P V Q G W D H G T T H L I N A A K L D E A N L P K E I N L V D D Y F E L V Q H E Y K K W Q E N S E Q G R R E G H A Q N P M E P S V P Q L S L M D V K C E T P N C P F F M S V N T Q P L C H E C S E R R Q K N Q N K L P K L N S K P G P E G L P G M A L G A S R
Fragment
50.95 kDa
50.8 kDa
2 to 439
Recombinant
Liquid
SDS-PAGE >= 95%
Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS-induced production of pro-inflammatory cytokines and IFN beta in LPS-tolerized macrophages.
Belongs to the peptidase C64 family.
Proteolytically cleaved by MALT1 upon TCR stimulation; disrupts NF-kappa-B inhibitory function and results in increased IL-2 production. It is proposed that only a fraction of TNFAIP3 colocalized with TCR and CBM complex is cleaved, leaving the main TNFAIP3 pool intact.
Nucleus, Lysosome
Dry Ice
-80°C
-80°C
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Mass determination by ESI-TOF. Predicted MW is 50952.56 Da (+/-10 Da by ESI-TOF). Observed MW is 50797.33 Da.
SDS-PAGE analysis of ab307487
HPLC analysis of ab307487
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com